E2F1 death pathways as targets for cancer therapy: Apoptosis Review Series

Journal of Cellular and Molecular Medicine

Volumn 11, Issue 2, 2007, Pages 239-251

  Putzer B M ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Apoptosis; Cancer; E2F1; Molecular therapy; Signalling pathways

Indexed keywords

E2F1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

APOPTOSIS; BIOLOGICAL MODEL; CELL DEATH; GENE EXPRESSION REGULATION; GENE TARGETING; GENETICS; HUMAN; METABOLISM; METHODOLOGY; NEOPLASM; REVIEW; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL DEATH; E2F1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GENE TARGETING; HUMANS; MODELS, GENETIC; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 34247882638     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2007.00030.x     Document Type: Review

References (112)

1. Ohtani K, DeGregori J, Nevins JR. Regulation of the cyclin E gene by transcription factor E2F. Proc Natl Acad Sci USA. 1995 92 : 12146 50.
2. Johnson DG, Schwarz JK, Cress WD, Nevins JR. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature. 1993 365 : 349 52.
3. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 1998 12 : 2245 62.
4. Müller H, Helin K. The E2F transcription factors: key regulators of cell proliferration. Biochim Biophys Acta. 2000 1470 : M1 2.
5. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995 81 : 323 30.
6. DeGregori J, Johnson DG. Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med. 2006 6 : 739 48.
7. Trimarchi JM, Lees JA. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol. 2002 3 : 11 20.
8. DeGregori J. The genetics of the E2F family of transcription factors: shared functions and unique roles. Biochim Biophys Acta. 2002 1602 : 131 50.
9. Logan N, Delavaine L, Graham A, Reilly C, Wilson J, Brummelkamp TR, Hijmans EM, Bernards R, La Thangue NB. E2F-7: a distinctive E2F family member with an unusual organization of DNA-binding domains. Oncogene. 2004 23 : 5138 50.
10. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA, Dynlacht BD. E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpoints. Genes Dev. 2002 16 : 245 56.
11. Dimova DK, Stevaux O, Frolov MV, Dyson NJ. Cellcycle-dependent and cell cycle-independent control of transcription by the Drosophila E2F/RB path-way. Genes Dev. 2003 17 : 2306 20.
12. Cam H, Balciunaite E, Blais A, Spector A, Scarpulla RC, Young R, Kluger Y, Dynlacht BD. A common set of gene regulatory networks links metabolism and growth inhibition. Mol Cell. 2004 16 : 399 411.
13. Bieda M, Xu X, Singer MA, Green R, Farnham PJ. Unbiased location analysis of E2F1-binding sites suggests a widespread role of E2F1 in human genome. Genome Res. 2006 16 : 595 605.
14. Stanelle J, Stiewe T, Theseling CC, Peter M, Pützer BM. Identification of novel E2F1-regulated target genes. Nucleic Acids Res. 2002 30 : 1859 67.
15. Ma Y, Croxton R, Moorer RL, Cress WD. Identification of novel E2F1-regulated genes by microarray. Arch Biochem Biophys. 2002 399 : 212 24.
16. Jamshidi-Parsian A, Dong Y, Zheng X, Zhou HS, Zacharias W, McMasters KM. Gene expression profiling of E2F-1-induced apoptosis. Gene. 2005 344 : 67 77.
17. Li Z, Stanelle J, Leurs C, Hanenberg H, Pützer BM. Selection of novel mediators of E2F1-induced apoptosis through retroviral expression of an antisense cDNA library. Nucleic Acids Res. 2005 33 : 2813 21.
18. Li Z, Kreutzer M, Mikkat S, Miše N, Glocker MO, Pützer BM. Proteomic analysis of the E2F1 response in p53-negative cancer cells: new aspects in the regulation of cell survival and death. Proteomics. 2006 6 : 5735 45.
19. Phillips AC, Vousden KH. E2F1 induced apoptosis. Apoptosis. 2001 6 : 173 82.
20. Ginsberg D. E2F1 pathways to apoptosis. FEBS Lett. 2002 529 : 122 5.
21. Sears RC, Nevins JR. Signaling networks that link cell proliferation and cell fate. J Biol Chem. 2002 277 : 11617 20.
22. La Thangue NB. The yin and yang of E2F-1: balancing life and death. Nat Cell Biol. 2003 5 : 587 9.
23. Lazzerini Denchi LE, Helin K. E2F1 is crucial for E2F-dependent apoptosis EMBO Rep. 2005 6 : 661 8.
24. Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell. 1996 85 : 537 48.
25. Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin WG Jr., Livingston DM, Orkin SH, Greenberg ME. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell. 1996 85 : 549 61.
26. Tsai KY, Hu Y, Macleod KF, Crowley D, Yamasaki L, Jacks T. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol Cell. 1998 2 : 293 304.
27. Hiebert SW, Packham G, Strom DK, Haffner R, Oren M, Zambetti G, Cleveland JL. E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol Cell Biol. 1995 15 : 6864 74.
28. Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL, Vousden KH. p14ARF links the tumour suppressors RB and p53. Nature. 1998 395 : 124 5.
29. Russell JL, Powers JT, Rounbehler RJ, Rogers PM, Conti CJ, Johnson DG. ARF differentially modulates apoptosis induced by E2F1 and Myc. Mol Cell Biol. 2002 22 : 1360 8.
30. Martelli F, Hamilton T, Silver DP, Sharpless NE, Bardeesy N, Rokas M, DePinho RA, Livingston DM, Grossman SR. p19ARF targets certain E2F species for degradation. Proc Natl Acad Sci USA. 2001 98 : 4455 60.
31. Rogoff HA, Pickering MT, Debatis ME, Jones S, Kowalik TF. E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis. Mol Cell Biol. 2002 22 : 5308 18.
32. Powers JT, Hong S, Mayhew CN, Rogers PM, Knudsen ES, Johnson DG. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis. Mol Cancer Res. 2004 2 : 203 14.
33. Hong S, Pusapati RV, Powers JT, Johnson DG. Oncogenes and the DNA damage response: Myc and E2F1 engage theATM signaling pathway to activate p53 and induce apoptosis. Cell Cycle. 2006 5 : 801 3.
34. Berkovich E, Ginsberg D. ATM is a target for positive regulation by E2F-1. Oncogene. 2003 22 : 161 7.
35. Hsieh JK, Yap D, O'Connor DJ, Fogal V, Fallis L, Chan F, Zhong S, Lu X. Novel function of the cyclin A binding site of E2F in regulating p53-induced apoptosis in response to DNA damage. Mol Cell Biol. 2002 22 : 78 93.
36. Phillips AC, Stewart S, Ryan KM, Helin K, Vousden KH. Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev. 1997 11 : 1853 63.
37. Hsieh J-K, Fredersdorf S, Kouzarides T, Martin K, Lu X. E2F-1 induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev. 1997 11 : 1840 52.
38. Holmberg C, Helin K, Sehested M, Karlstrom O. E2F-1 induced p53-independent apoptosis in transgenic mice. Oncogene. 1998 17 : 143 55.
39. Haas-Kogan DA, Kogan S, Levi D, Dazin P, T'Ang A, Fung YK Israel MA. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J. 1995 14 : 461 72.
40. Stiewe T, Pützer BM. Role of the p53 homolog p73 for E2F1-induced apoptosis. Nat Genet. 2000 26 : 464 9.
41. Irwin M, Martin MC, Phillips AC, Seelan RS, Smith DI, Liu W, Flores ER, Tsai KY, Jacks T, Vousden KH, Kaelin WG Jr. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature. 2000 407 : 645 8.
42. Moroni MC, Hickman ES, Denchi EL, Caprara G, Colli E, Cecconi F, Mller H, Helin K. Apaf-1 is a transcriptional target for E2F1 and p53. Nat Cell Biol. 2001 3 : 552 8.
43. Stanelle J, Stiewe T, Rödicker F, Köhler K, Theseling CC, Pützer BM. Mechanisms of E2F1-induced apoptosis in primary vascular smooth muscle cells. Cardiovasc Res. 2003 59 : 512 9.
44. Bell LA, O'Prey J, Ryan KM. DNA-binding independent cell death from a minimal proapoptotic region of E2F-1. Oncogene. 2006 25 : 5656 63.
45. Hallstrom TC, Nevins JR. Specificity in the activation and control of transcription factor E2F-dependent apoptosis. Proc Natl Acad Sci USA. 2003 100 : 10848 53.
46. Chaussepied M, Ginsberg D. Transcriptional regulation of AKT activation by E2F. Mol Cell. 2004 16 : 831 7.
47. Moon NS, Di Stefano L, Dyson N. A gradient of epidermal growth factor receptor signaling determines the sensitivity of rbf1 mutant cells to E2F-dependent apoptosis. Mol Cell Biol. 2006 26 : 7601 15.
48. Lin WC, Lin FT, Nevins JR. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev. 2001 15 : 1833 44.
49. Pediconi N, Ianari A, Costanzo A, Belloni L, Gallo R, Cimino L, Porcellini A, Screpanti I, Balsano C, Alesse E, Gulino A, Levrero M. Differential regulation of E2F1 apoptotic target genes in response to DNA damage. Nat Cell Biol. 2003 5 : 552 8.
50. Ianari A, Gallo R, Palma M, Alesse E, Gulino A. Specific role for p300/CREB-binding protein-associated factor activity in E2F1 stabilization in response to DNA damage. J Biol Chem. 2004 279 : 30830 5.
51. Banerjee D, Schnieders B, Fu J, Ashikari D, Zhao S-C, Bertino J. Role of E2F-1 in chemosensitivity. Cancer Res. 1998 58 : 4292 6.
52. Meng R, Phillips P, El-Deiry W. p53-independent increasein E2F-1 expression enhances the cytotoxic effects of etoposide and adriamycin. Int J Oncol. 1999 14 : 5 14.
53. Pruschy M, Wirbelauer C, Glanzmann C, Bodis S, Krek W. E2F-1 has properties of a radiosensitizer and its regulation by cyclin A kinase is required for cell survival of fibrosarcoma cells lacking p53. Cell Growth Differ. 1999 10 : 141 6.
54. Ršdicker F, Stiewe T, Zimmermann S, Pützer BM. Therapeutic efficacy of E2F1 in pancreatic cancer correlates with TP73 induction. Cancer Res. 2001 61 : 7052 5.
55. Polager S, Kalma Y, Berkovich E, Ginsberg D. E2Fs up-regulate expression of genes involved in DNA replication, DNA repair and mitosis. Oncogene. 2002 21 : 437 46.
56. Hao H, Dong YB, Bowling MT, Zhou HS, McMasters KM. Alteration of gene expression in melanoma cells following combined treatment with E2F-1 and doxorubicin. Anticancer Res. 2006 26 : 1947 56.
57. Blattner C, Sparks A, Lane D. Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53. Mol Cell Biol. 1999 19 : 3704 13.
58. Stevens C, Smith L, La Thangue NB. Chk2 activates E2F-1 in response to DNA damage. Nat Cell Biol. 2003 5 : 401 9.
59. Moon N-S, Frolov MV, Kwon E-J, Di Stefano L, Dimova DK, Morris EJ, Taylor-Harding B, White K, Dyson NJ. Drosophila E2F1 has context-specific pro- and antiapoptotice properties during development. Dev Cell. 2005 9 : 463 75.
60. Nip J, Strom D, Fee B, Zamberti G, Cleveland J, Hiebert S. E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis. Mol Cell Biol. 1997 17 : 1049 56.
61. Hofland K, Petersen B, Falck J, Helin K, Jensen P, Sehested M. Differential cytotoxic pathways of topoi-somerase I and II anticancer agents after overex-pression of the E2F-1/DIP-1 transcription factor complex. Clin Cancer Res. 2000 6 : 1488 97.
62. Stiewe T, Zimmermann S, Frilling A, Esche H, Pützer BM. Transactivation-deficient N-p73 acts as an oncogene. Cancer Res. 2002 62 : 3598 602.
63. Irwin MS, Kondo K, Marin MC, Cheng LS, Hahn WC, Kaelin WG Jr. Chemosensitivity linked to p73 function. Cancer Cell. 2003 3 : 403 10.
64. Tuve S, Racek T, Niemetz A, Schultz J, Soengas MS, Pützer BM. Adenovirus-mediated TA-p73 gene transfer increases chemosensitivity of human malignant melanomas. Apoptosis. 2006 11 : 235 45.
65. Hershko T, Ginsberg D. Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis. J Biol Chem. 2004 279 : 8627 34.
66. Real PJ, Sanz C, Gutierrez O, Pipaon C, Zubiaga AM, Fernandez-Luna JL. Transcriptional activation of the proapoptotik bik gene by E2F proteins in cancer cells. FEBS Lett. 2006 580 5905 9.
67. Bouillet P, Strasser A. Bax and Bak: back-bone of T cell death. Nat Immunol. 2002 3 : 893 4.
68. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, Colman PM, Day CL, Adams JM, Huang DC. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell. 2005 17 : 393 403.
69. Stanelle J, Tu-Rapp H, Pützer BM. A novel mito-chondrial protein DIP mediates E2F1-induced apoptosis indepently of p53. Cell Death Differ. 2005 12 : 347 57.
70. Xie W, Jiang P, Miao L, Zhao Y, Zhimin Z, Qing L, Zhu WG, Wu M. Novel link between E2F1 and Smac/DIABOLO: proapoptotic Smac/DIABOLO is transcriptionally upregulated by E2F1. Nucleic Acids Res. 2006 34 : 2046 55.
71. Nahle Z, Polakoff J, Davuluri RV, Mc Currach ME, Jacobson MD, Narita M, Zhang MQ, Lazebrink Y, Bar-Sagi D, Lowe SW. Direct coupling of the cell cycle and cell death machinery by E2F. Nat Cell Biol. 2002 4 : 859 64.
72. Fortin A, MacLaurin JG, Arbour N, Cregan SP, Kushwaha N, Callaghan SM, Park DS, Albert PR, Slack RS. The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1. J Biol Chem. 2004 279 : 28706 14.
73. Xue L, Chu F, Cheng Y, Sun X, Borthakur A, Ramarao M, Pandey P, Wu M, Schlossman SF, Prasad KVS. SIVA binds to and inhibits BCL-XL-mediated protection against UV radiation-induced apoptosis. Proc Natl Acad Sci USA. 2002 99 : 6925 30.
74. Qin LF, Lee TK, Ng IO. Gene expression profiling by cDNA array in human hepatoma cell line in response to cisplatin treatment. Life Sci. 2002 70 : 1677 90.
75. Hershko T, Korotayev K, Polager S, Ginsberg D. E2F1 modulates p38 MAPK phosphorylation via transcriptional regulation of ASK1 and Wip1. J Biol Chem. 2006 281 : 31309 16.
76. Kherrouche Z, Blais A, Ferreira E, De Launoit Y, Monte D. ASK-1 (apoptosis signal-regulating kinase 1) is a direct E2F1 target gene. Biochem J. 2006 396 : 547 56.
77. Mller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E, Prosperini E, Vigo E, Oliner JD, Helin K. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 2001 15 : 267 85.
78. Huang S, Shu L, Dilling MB, Easton J, Harwood FC, Ichijo H, Houghton PJ. Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21Cip1. Mol Cell. 2003 11 : 1491 501.
79. Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumuro K, Mizutani S. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J. 1999 18 : 1223 34.
80. Fogal V, Kartasheva NN, Trigiante G, Llanos S, Yap D, Vousden KH, Lu X. ASPP1 and ASPP2 are new transcriptional targets of E2F. Cell Death Differ. 2005 12 : 369 76.
81. Hershko T, Chaussepied M, Oren M, Ginsberg D. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F. Cell Death Differ. 2005 12 : 377 83.
82. Samuels-Lev Y, O'Connor DJ, Bergamaschi D, Trigiante G, Hsieh U-K, Zhong S, Campargue I, Naumovski L, Crook T, Lu X. ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell. 2001 8 : 781 94.
83. Chen D, Padiernos E, Ding F, Lossos IS, Lopez CD. Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene. Cell Death Differ. 2005 12 : 358 68.
84. Matarrese P, Tinari A, Mormone E, Bianco GA, Toscano MA, Ascione B, Rabinovich GA, Malorni W. Galectin-1 sensitizes resting human T lympho-cytes to Fas (CD95)-mediated cell death via mito-chondrial hyperpolarization, budding, and fission. J Biol Chem. 2005 280 : 6969 85.
85. Cao Q, Xia Y, Azadniv M, Crispe IN. The E2F-1 transcription factor promotes caspase-8 and bid expression, and enhances Fas signaling in T cells. J Immunol. 2004 173 : 1111 7.
86. Lissy NA, Davis PK, Irwin M, Kaelin WG, Dowdy SF. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature. 2000 407 : 642 5.
87. Chen G, Goedell DV. TNF-R1 signaling: a beautiful pathway. Science. 2002 296 : 1634 35.
88. Phillips AC, Ernst MK, Bates S, Rice NR, Vousden KH. E2F-1 potentiates cell death by blocking anti-apoptotic signaling pathways. Mol Cell. 1999 4 : 771 81.
89. Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, Cleveland JL. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1. Oncogene. 2001 20 : 6983 93.
90. Croxton R, Ma Y, Song L, Haura EB, Cress WD. Direct repression of the Mcl-1 promoter by E2F1. Oncogene. 2002 21 : 1359 69.
91. Kim R, Emi M, Tanabe K, Murakami S. Role of the unfolded protein response in cell death. Apoptosis. 2006 11 : 5 13.
92. Rao RV, Castro-Obregon S, Frankowski H, Schuler M, Stoka V, del Rio G, Bredesen DE, Ellerby HM. Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway. J Biol Chem. 2002 277 : 21836 42.
93. Scorrano L, Oakes SA, Opferman JT, Cheng EH, Sorcinelli MD, Pozzan T, Korsmeyer SJ. BAX and BAK regulation of endoplasmic reticulum Ca2+:a control point for apoptosis. Science. 2003 300 : 135 9.
94. Reddy RK, Mao C, Baumeister P, Austin RC, Kaufman RJ, Lee AS. Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation. J Biol Chem. 2003 278 : 20915 24.
95. Miyake H, Hara I, Arakawa S, Kamidono S. Stress protein GRP78 prevents apoptosis induced by calcium ionophore, ionomycin, but not by glycosylation inhibitor, tunicamycin, in human prostate cancer cells. J Cell Biochem. 2000 77 : 396 408.
96. Wang XP, Liu GZ, Song AL, Chen RF, Li HY, Liu Y. Expression and significance of heat shock protein 70 and glucose-regulated protein 94 in human esophageal carcinoma. World J Gastroenterol. 2005 11 : 429 32.
97. Roemer K, Friedmann T. Mechanisms of action of the p53 tumor suppressor and prospects for cancer gene therapy by reconstitution of p53 function. Ann N Y Acad Sci. 1994 716 : 265 80.
98. Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordon-Cardo C, Lowe SW. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature. 2001 409 : 207 11.
99. Polyak K, Waldman T, He TC, Kinzler KW, Vogelstein B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 1996 10 : 1945 52.
100. Fueyo J, Gomez-Manzano C, Yung WKA, Liu TJ, Alemany R, McDonnell TJ, Shi X, Rao JS, Levin VA, Kyritsis AP. Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo. Nat Med. 1998 4 : 685 90.
101. Dong YB, Yang HL, Elliott MJ, Liu TJ, Stilwell A, Atienza C, McMasters KM. Adenovirus-mediated E2F-1 gene transfer efficiently induces apoptosis in melanoma cells. Cancer. 1999 86 : 2021 33.
102. Yang H, Dong Y, Elliott M, Liu T, Atienza CJ, Stilwell A, McMasters KM. Adenovirus-mediated E2F-1 gene transfer inhibits MDM2 expression and efficiently induces apoptosis in MDM2-overexpressing tumor cells. Clin Cancer Res. 1999 5 : 2242 50.
103. Yang H, Dong Y, Elliott M, Liu T, McMasters K. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1 mediated apoptosis in human esophadeal cancer cells. Clin Cancer Res. 2000 6 : 1579 89.
104. Hunt KK, Deng J, Liu TJ, Wilson-Heiner N, Swisher SG, Clayman G, Hung MC. Adenovirusmediated overexpression of the transcription factor E2F1 induces apoptosis in human breast cancer and ovarian carcinoma cell lines and does not require p53. Cancer Res. 1997 57 : 4722 6.
105. Liu T, Wang M, Breau R, Henderson Y, El-Naggar A, Steck K, Sicard MW, Clayman GL. Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines. Cancer Gene Ther. 1999 6 : 163 71.
106. Atienza C, Elliott MJ, Dong YB, Yang HI, Stilwell A, Liu TJ, McMasters KM. Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors. Int J Mol Med. 2000 6 : 55 63.
107. Kuhn H, Liebers U, Gessner C, Schumacher A, Witt C, Schauer J, Kovesdi I, Wolff G. Adenovirusmediated E2F-1 gene transfer in nonsmall-cell lung cancer induces cell growth arrest and apoptosis. Eur Respir J. 2002 20 : 703 9.
108. Parr MJ, Manome Y, Tanaka T, Wen P, Kufe DW, Kaelin WG Jr., Fine HA. Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector. Nat Med. 1997 3 : 1145 9.
109. Rödicker F, Pützer BM. p73 is effective in p53-null pancreatic cancer cells resistant to wild-type TP53 gene replacement. Cancer Res. 2003 63 : 2737 41.
110. Das S, Nama S, Antony S, Somasundaram K. p73beta-expressing recombinant adenovirus: a potential anticancer agent. Cancer Gene Ther. 2005 12 : 417 26.
111. Schlagbauer-Wadl H, Klosner G, Heere-Ress E, Waltering S, Moll I, Wolff K, Pehamberger H, Jansen B. Bcl-2 antisense oligonucleotides (G3139) inhibit Merkel cell carcinoma growth in SCID mice. J Invest Dermatol. 2000 114 : 725 30.
112. Badros AZ, Goloubeva O, Rapaport AP, Ratterree B, Gahres N, Meisenberg B, Takebe N, Heyman M, Zwiebel J, Steicher H, Gocke CD, Tomic D, Flaws JA, Zhang B, Fenton RG. Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients. J Clin Oncol. 2005 23 : 4089 99.